Autologous stem cell transplantation for advanced acute myeloid leukemia

[1]  F. Gherlinzoni,et al.  Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells , 1999, Bone Marrow Transplantation.

[2]  A. Hagenbeek,et al.  Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia? , 1999, Bone Marrow Transplantation.

[3]  H. Rugo,et al.  Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report , 1998, Bone Marrow Transplantation.

[4]  N. Gorin.  Autologous stem cell transplantation in acute myelocytic leukemia. , 1998, Blood.

[5]  J. Román,et al.  Autologous peripheral blood stem cell transplantation (PBSCT) mobilized with G-CSF in AML in first complete remission. Role of intensification therapy in outcome , 1998, Bone Marrow Transplantation.

[6]  M. Labopin,et al.  Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS , 1997 .

[7]  K. Akashi,et al.  Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia , 1997, Bone Marrow Transplantation.

[8]  M. Vignetti,et al.  Autologous Bone Marrow Transplantation for Acute Promyelocytic Leukemia in Second Remission: Prognostic Relevance of Pretransplant Minimal Residual Disease Assessment by Reverse-Transcription Polymerase Chain Reaction of the PML/RARα Fusion Gene , 1997 .

[9]  M. Vignetti,et al.  BAVC regimen and autograft for acute myelogenous leukemia in second complete remission. , 1996, Bone marrow transplantation.

[10]  J. Niland,et al.  In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  M. Labopin,et al.  Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT). , 1996, Bone marrow transplantation.

[12]  H. Rugo,et al.  Autologous stem cell transplantation for acute myeloid leukemia in first remission. , 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  M. Labopin,et al.  Autologous blood cell vs marrow transplantation for acute myeloid leukemia in complete remission: an EBMT retrospective analysis , 2000, Bone Marrow Transplantation.

[14]  M. Vignetti,et al.  Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion gene. , 1997, Blood.